I included it as an attachment, although it doesn’t explicitly say that it even needs to be included. But we always included it in the old days!

Jeanne McCabe, CPA, MBA

Director, Research Administration

BloodCenter of Wisconsin, Inc.

Blood Research Institute

PO Box 2178

Milwaukee, WI 53201-2178

Courier Deliveries: 8727 Watertown Plank Rd

Milwaukee, WI 53226-3548

Phone: 414-937-6355

Fax: 414-937-6284

Cell: 414-333-9270

xxxxxx@bcw.edu

From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Erin C Davis
Sent: Friday, June 05, 2009 7:58 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] ARRA construction grants, NIH policy Part II, Subpart B, and public disclosure clause

Are people submitting a copy of the PUBLIC disclosure in the application package, and if so... Where? As a part of one of the attachments????
Thanks for your collective wisdom!!!

ERIN C. DAVIS
Grants Development Specialist II
Office of Research Guidance, E-275
Wadsworth Center, NYS DOH
Empire State Plaza
P.O. Box 509
Loading Dock J (use in lieu of PO Box when sending via courier)
Albany, NY 12201-0509

(518) 474-6602 (phone)
(518) 402-5540 (fax)

"Dolce, Peter J" <xxxxxx@MMC.EDU>

"Dolce, Peter J" <xxxxxx@MMC.EDU>
Sent by: Research Administration List <xxxxxx@hrinet.org>

06/04/2009 07:13 PM

Please respond to
Research Administration Discussion List <xxxxxx@hrinet.org>

xxxxxx@hrinet.org

Subject

Re: [RESADM-L] ARRA construction grants, NIH policy Part II, Subpart B, and public disclosure clause

Yes. The two requirements aren’t connected.

Peter J. Dolce, Ph.D.
Associate Vice President for Research
Meharry Medical College
West Basic Sciences Center
1023 21st Avenue North
Nashville, TN 37208

Phone 615 327 6237
Fax 615 327 6144

From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Schmitt, Andrea L
Sent: Thursday, June 04, 2009 4:29 PM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] ARRA construction grants, NIH policy Part II, Subpart B, and public disclosure clause

do you need to submit a public notice if your state doesn't have a SPOC?
thanks,
Andrea

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Andrea Schmitt
Grants Manager
Sun Health Research Institute
10515 West Santa Fe Dr.
Sun City, AZ 85351
623-876-5628
623-876-5461 (fax)
xxxxxx@bannerhealth.com

From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of Sondra Floyd
Sent: Monday, April 13, 2009 2:47 PM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] ARRA construction grants, NIH policy Part II, Subpart B, and public disclosure clause
Ivona-

You only need to state that LA does not participate in the SPOC program.

Each project needs its own notice and I would submit it with the package.

Sondra

>>> Ivona Jukic <xxxxxx@ULM.EDU> 4/13/2009 3:14 PM >>>

Hi everyone,

I would like to ask for your opinion on ARRA NIH construction grants (C06 and G20) and NIH policy Part II, Subpart B.

According to Subpart II, we are supposed to issue public disclosure concurrent with notification to SPOC.

First, we (Louisiana) do not have a SPOC for DHHS. Still, section Intergovernmental Review under E.O.12372 states that SPOCs are given 60 days to review the application. To accommodate this time frame and the NIH review process, an applicant must provide a copy of the application to the SPOC no later than the time the application is submitted to NIH. SPOC comments must be submitted to NIH with the application, or the application must indicate the date on which the application was provided to the SPOC for review. If SPOC comments are not submitted with the application, the applicant must provide them upon receipt and may include its reaction to the comments, or it must notify NIH that it did not receive any SPOC response. Apart from SF424's place for E.O. where else and would you address this in your application?

Also, would you issue multiple public disclosures for each individual projects (5 total since limitted submission rule applies)? Would you publish these prior to the deadline and attach a copy of it to you package?

Public Disclosure:

Section 102 of NEPA and EO 11514 (March 5, 1970) provide for public comment and participation in the environmental impact review process. Applicants are required to publicly disclose the project in a newspaper or other publicly available medium and to describe its environmental impact concurrent with notification to the SPOC (see "Intergovernmental Review under Executive Order 12372" in this section).

OR, is it none of the above?

Thank you,

Ivona

Ivona Jukic
Grants Manager
Office of Sponsored Programs & Research
University Library 211
University of Louisiana at Monroe
Monroe, LA 71209
(p) 318.342.1476
(f) 318.342.1479
http://ulm.edu/research

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

Individuals who have received this information in error or are not authorized to receive it must promptly return or dispose of the information and notify the sender. Those individuals are hereby notified that they are strictly prohibited from reviewing, forwarding, printing, copying, distributing or using this information in any way.

DISCLAIMER: This email and any files transmitted with it may be privileged, confidential, and contain health information that is legally protected. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless permitted to do so by law or regulation. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution, is strictly prohibited. If you have received this information in error, please notify the sender immediately and arrange for the return or destruction of these documents.

IMPORTANT NOTICE: This e-mail and any attachments may contain confidential or sensitive information which is, or may be, legally privileged or otherwise protected by law from further disclosure. It is intended only for the addressee. If you received this in error or from someone who was not authorized to send it to you, please do not distribute, copy or use it or any attachments. Please notify the sender immediately by reply e-mail and delete this from your system. Thank you for your cooperation.

*********** CONFIDENTIALITY NOTICE ***********
This transmission may contain confidential information. If you have
received this transmission in error, please notify the sender
immediately and destroy this material.